Synthetic Biology — Designing Life from Scratch

The smallest known genome capable of self-replication has 473 genes. Of those, 149 perform functions no scientist can explain — a third of the genetic code for life, operating in biological darkness.

Synthetic biology is not genetic engineering by another name. It is the effort to build living systems from standardized parts, writing genomes like software and booting them into cells as if initializing a machine. Since 2010, when the J. Craig Venter Institute (JCVI) synthesized a 1.08 million base-pair genome and transplanted it into a host cell, biology has shifted from reading DNA to writing it. But the minimal cell achieved in 2016 — JCVI-syn3.0 — revealed something humbling: simplification unmasked ignorance. The core of life, stripped bare, still contains 149 essential but uncharacterized genes.

How it works: From DNA as code to cells as factories

In 2000, researchers built the first synthetic gene circuits — a toggle switch and a genetic oscillator — in E. coli, proving that biological components could be wired like electronic circuits. Since then, the discipline has scaled. Genetic sequences are now designed in software, synthesized chemically, and assembled into functional genomes. The cell becomes a chassis; the genome, a user-installed operating system.

The workflow runs through biofoundries — robotic labs that automate the design-build-test cycle. Ginkgo Bioworks in Boston and the Edinburgh Genome Foundry run hundreds of constructs in parallel, iterating designs in days. DNA synthesis costs have fallen from $4 per base pair in 2000 to $0.02 in 2025. At that rate, synthesizing a human genome (3 billion base pairs) would cost ~$60 million — not trivial, but no longer science fiction.

This infrastructure enables whole-cell engineering. JCVI-syn1.0 (2010) used a natural Mycoplasma mycoides genome, chemically synthesized and "booted" in a recipient cell. But JCVI-syn3.0 (2016) was different: a genome stripped to its bare essentials through systematic gene deletions. It ended at 531,000 base pairs and 473 genes. The cells divided — but erratically, producing branched, filamentous progeny unlike any natural bacterium. The genes removed weren’t redundant; they maintained geometric fidelity in division, a function invisible until it was gone.

In 2025, a 4D computational model simulated the entire cell cycle of JCVI-syn3.0, tracking molecular interactions in space and time. It reproduced the abnormal division patterns, confirming that morphology emerges from network-level dynamics, not just gene presence.

Where it shows up: Xenobots, anthrobots, and living buildings

Outside the test tube, synthetic biology is producing forms of life with no precedent.

In 2020, researchers at Tufts and UVM used frog (Xenopus laevis) stem cells to create xenobots — millimeter-scale aggregates that move via cilia and engage in kinematic self-replication. No genetic modification was made. Instead, an evolutionary algorithm designed shapes optimized for locomotion, and those shapes were assembled in the lab. The xenobots gathered loose cells into new xenobots — a form of replication never seen in nature.

In 2024, the same lab built anthrobots from adult human tracheal cells. These formed motile structures that, when placed over damaged neuron monolayers, migrated to injury sites and promoted regrowth. The cells had no history of neural repair. The behavior emerged from collective dynamics, not hard-coded programming.

Meanwhile, at NASA Ames, the Myco-Architecture program is growing buildings from fungal mycelium. Astronauts would carry dormant fungal scaffolds to Mars or the Moon. With water, the mycelium grows into structural forms with:

Compressive strength exceeding pine lumber
Flexural strength surpassing reinforced concrete
Self-sealing properties: punctures regrow in days
Full biodegradability

The program received $2 million in 2024 to scale to Phase III. A 2025 presentation at the Lunar and Planetary Science Conference showed load-bearing wall prototypes grown in simulated Mars regolith.

NASA is also testing synthetic biology for life support. The BioNutrients experiment on the ISS uses freeze-dried yeast engineered to produce beta-carotene and zeaxanthin — critical antioxidants absent in stored food — on demand when rehydrated. The LEIA mission (2026–2027) will deploy yeast on the lunar surface to study their response to radiation and low gravity, informing future designs for in-situ resource utilization.

What's contested: Is a cell just a program, or does it have latent cognition?

The anthrobot experiments challenge a core assumption: that cell behavior is determined by lineage and gene expression. Human tracheal cells, never selected by evolution to repair neurons, do so anyway when freed from their tissue context. Michael Levin argues this is evidence of distributed cognition — that cells possess problem-solving capabilities independent of nervous systems.

This view is contested. Mainstream molecular biology holds that behavior emerges from gene-regulatory networks, not cellular agency. But if so, then why do tracheal cells “know” how to repair neurons? No gene circuit for this function has been identified. The alternative — that cells operate with a form of embodied intelligence — lacks a mechanistic framework. The dispute is not just technical; it questions what life is. Are we managing programs, or awakening systems with goals?

There’s also a practical limit: we can synthesize genomes, but we cannot predict their behavior in full. The JCVI-syn3.0 cell divides abnormally. The 149 unknown-function genes are essential — remove any, and the cell dies — but their biochemical roles remain opaque. This is akin to running an operating system where a third of the code is uncommented and untraceable, yet the system crashes if any line is deleted.

Why this has to do with other realms

Synthetic biology blurs the boundary between life and machine — a line that matters in computing and space alike. Xenobots are literal examples of hardware designed by software: evolutionary algorithms at a supercomputer produced a lifeform, which was then assembled in the lab. That process is indistinguishable from manufacturing, except the product is alive. This links directly to concept swarm intelligence — not because xenobots are intelligent, but because their collective motion and replication mirror decentralized computation, like ants building a nest.

In space, synthetic biology isn’t just a tool — it’s a shift in logistics. A kilogram of dormant fungal spores can grow a habitat; a vial of yeast can replace tons of food shipments. But this also forces a confrontation with concept tardigrades: if we’re sending self-replicating systems to other planets, we must ask whether they should be engineered with built-in limits, as tardigrades are by evolution. A mycelium structure that spreads uncontrollably on Mars would compromise planetary protection protocols and ruin scientific search for native life.

An open question

If human tracheal cells can sense and repair neural damage without a brain, what other functions lie dormant in our tissues — and who, or what, is doing the healing?

Key sources

Hutchison et al., "Design and synthesis of a minimal bacterial genome," Science (2016) — the JCVI-syn3.0 paper, defining the 473-gene minimal genome.
Kriegman et al., "A scalable pipeline for designing reconfigurable organisms," PNAS (2020) — the xenobot design and self-replication experiments.
Kandhari et al., "Anthrobots self-assemble from adult human cells and show motility and wound repair," Advanced Science (2024) — the anthrobot study.
NASA Myco-Architecture Project — Phase III funding announcement (2024), LPSC 2025 abstracts.
to verify: full 4D simulation details of JCVI-syn3.0 — presented in part at 2025 Biophysical Society meeting.

Abhishek